Literature DB >> 8016028

Cancer control at the workplace: the Working Well Trial.

D B Abrams1, W B Boutwell, J Grizzle, J Heimendinger, G Sorensen, J Varnes.   

Abstract

BACKGROUND. Few research studies have been conducted on cancer prevention and control at the workplace. This article presents an overview of the largest worksite cancer control trial in the United States--The Working Well Trial--conducted in 114 worksites by four study centers, a coordinating center, and the National Cancer Institute. The trial's organizational structure, research design, dependent measures, and theoretical model for intervention are described. Special features of the trial include using the worksite as the unit of randomization, intervention, and evaluation and a theory-driven conceptual model of intervention that places emphasis on individual and organizational targets for change, uses the transtheoretical stage of change model to guide a sustained 2-year multiple risk factor intervention, and makes use of volunteer resources within the worksite to reduce cost, increase participation, and improve tailoring to individual needs. The trial will have a potential impact on over 25,000 workers. CONCLUSION. The issues raised in this overview have implications for the evaluation and dissemination of cancer prevention and control programs to defined populations.

Entities:  

Mesh:

Year:  1994        PMID: 8016028     DOI: 10.1006/pmed.1994.1003

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  22 in total

1.  Identifying best practices of community participation in providing services to refugee survivors of torture: a case description.

Authors:  Anila Ramaliu; Wilfreda E Thurston
Journal:  J Immigr Health       Date:  2003-10

Review 2.  Reducing social disparities in tobacco use: a social-contextual model for reducing tobacco use among blue-collar workers.

Authors:  Glorian Sorensen; Elizabeth Barbeau; Mary Kay Hunt; Karen Emmons
Journal:  Am J Public Health       Date:  2004-02       Impact factor: 9.308

Review 3.  Design and analysis of group-randomized trials: a review of recent practices.

Authors:  Sherri P Varnell; David M Murray; Jessica B Janega; Jonathan L Blitstein
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

4.  Worksite Environmental Interventions for Obesity Prevention and Control: Evidence from Group Randomized Trials.

Authors:  Isabel Diana Fernandez; Adan Becerra; Nancy P Chin
Journal:  Curr Obes Rep       Date:  2014-06

5.  Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: a combined stepped-care and matching model.

Authors:  D B Abrams; C T Orleans; R S Niaura; M G Goldstein; J O Prochaska; W Velicer
Journal:  Ann Behav Med       Date:  1996

6.  Take Heart II: replication of a worksite health promotion trial.

Authors:  R E Glasgow; J R Terborg; L A Strycker; S M Boles; J F Hollis
Journal:  J Behav Med       Date:  1997-04

Review 7.  Multiple risk factor interventions for primary prevention of coronary heart disease.

Authors:  S Ebrahim; A Beswick; M Burke; G Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

8.  Take heart: results from the initial phase of a work-site wellness program.

Authors:  R E Glasgow; J R Terborg; J F Hollis; H H Severson; S M Boles
Journal:  Am J Public Health       Date:  1995-02       Impact factor: 9.308

9.  Exploring the role of co-worker social support on health care utilization and sickness absence.

Authors:  Sara L Tamers; Shirley A A Beresford; Beti Thompson; Yingye Zheng; Allen D Cheadle
Journal:  J Occup Environ Med       Date:  2011-07       Impact factor: 2.162

10.  Acceptability of testing children for tobacco-smoke exposure: a national parent survey.

Authors:  Jonathan P Winickoff; Susanne E Tanski; Robert C McMillen; Kaile M Ross; Ellen A Lipstein; Bethany J Hipple; Joan Friebely; Jonathan D Klein
Journal:  Pediatrics       Date:  2011-03-21       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.